The antidote: inside the world of new pharma

Book Cover
Average Rating
Author:
Publisher:
Varies, see individual formats and editions
Pub. Date:
2014
Language:
English
Description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success. The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
Also in This Series
More Like This
More Details
ISBN:
9781451655674
9781451655667
9781452699882
Reviews from GoodReads
Loading GoodReads Reviews.
Staff View

Grouping Information

Grouped Work ID5e330a79-d695-f68d-092d-1d0e297122b4
Grouping Titleantidote inside the world of new pharma
Grouping Authorbarry werth
Grouping Categorybook
Grouping LanguageEnglish (eng)
Last Grouping Update2024-03-14 20:29:42PM
Last Indexed2024-03-27 22:58:32PM

Solr Fields

accelerated_reader_point_value
0
accelerated_reader_reading_level
0
auth_author2
Pratt, Sean
author
Werth, Barry
author2-role
Pratt, Sean,reader
hoopla digital
author_display
Werth, Barry
display_description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success. The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
format_category_eh
Audio Books
Books
eBook
format_eh
Book
eAudiobook
id
5e330a79-d695-f68d-092d-1d0e297122b4
isbn
9781451655667
9781451655674
9781452699882
itype_eh
ADULT BOOK
last_indexed
2024-03-28T04:58:32.561Z
lexile_score
-1
literary_form
Non Fiction
literary_form_full
Non Fiction
primary_isbn
9781451655674
publishDate
2014
publisher
Simon & Schuster
Tantor Media, Inc
recordtype
grouped_work
subject_facet
Biotechnology
Business
Drugs -- Marketing
Economics
Pharmaceutical industry -- United States
Vertex Pharmaceuticals Incorporated
title_display
The antidote : inside the world of new pharma
title_full
The Antidote : inside the world of new pharma [electronic resource] / Barry Werth
The antidote : inside the world of new pharma / Barry Werth
title_short
The antidote
title_sub
inside the world of new pharma
topic_facet
Biotechnology
Business
Drugs
Economics
Marketing
Pharmaceutical industry

Solr Details Tables

item_details

Bib IdItem IdShelf LocCall NumFormatFormat CategoryNum CopiesIs Order ItemIs eContenteContent SourceeContent URLDetailed StatusLast CheckinLocation
ils:.b23022449.i50010098East Lyme Public Adult Non-Fiction338.4761 Werth1falsefalseOn Shelfelan
ils:.b23022449.i49998006Meriden Adult Non-Fiction338.4 WE1falsefalseMissingmean
ils:.b23022449.i50002971Wallingford Adult Nonfiction338.4761 WERTH1falsefalseOn Shelfwaan
hoopla:MWT11412342Online Hoopla CollectionOnline HooplaeAudiobookAudio Books1falsetrueHooplahttps://www.hoopladigital.com/title/11412342?utm_source=MARC&Lid=hh4435Available Online

record_details

Bib IdFormatFormat CategoryEditionLanguagePublisherPublication DatePhysical DescriptionAbridged
ils:.b23022449BookBooksFirst Simon & Schuster hardcover editionEnglishSimon & Schuster2014x, 435 pages : illustration ; 25 cm
hoopla:MWT11412342eAudiobookAudio BooksUnabridgedEnglishTantor Media, Inc20141 online resource (1 audio file (16hr., 27 min.)) : digital.

scoping_details_eh

Bib IdItem IdGrouped StatusStatusLocally OwnedAvailableHoldableBookableIn Library Use OnlyLibrary OwnedHoldable PTypesBookable PTypesLocal Url
ils:.b23022449.i50010098On ShelfOn Shelffalsetruetruefalsefalsefalse9999
ils:.b23022449.i49998006Currently UnavailableMissingfalsefalsefalsefalsefalsefalse
ils:.b23022449.i50002971On ShelfOn Shelffalsetruetruefalsefalsefalse9999
hoopla:MWT11412342Available OnlineAvailable Onlinefalsetruefalsefalsefalsefalse